Bi-aryl meta-pyrimidine inhibitors of kinases

BNRE20190007BUndetermined Publication Date: 2019-05-28IMPACT BIOMEDICINES INC

0 Cites 0 Cited by

Patent Information

Application Number: BNRE20190007
Authority / Receiving Office: BN · BN
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2005-11-01
Filing Date: 2006-10-26
Publication Date: 2019-05-28
Estimated Expiration: 2026-10-26

Application Information

Patent Timeline

01 Nov 2005

Priority

26 Oct 2006

Application

BNRE20190007

28 May 2019

Publication

BNRE20190007B

IPC: A61K; C07D

Inventors: CAO, JON, JIANGUO; HOOD, JOHN

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Smart Images

Figure IMAGE_001

Patent Text Reader

Abstract

The invention provides biaryl meta-pyrimidine compounds having the general structure ( A ). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinases family, and various other specific receptor and non receptor kinases.

Need to check novelty before this filing date? Find Prior Art